Related Experiment Video
Updated: Dec 30, 2025

10:49
Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
Published on: September 20, 2016
13.1K
Probing biological mechanisms with chemical tools
Congbao Kang1, Thomas H Keller1
1Experimental Drug Development Centre (EDDC), Agency for Science, Technology and Research (A*STAR), 10 Biopolis Road, Chromos, #05-01, 138670, Singapore.
Pharmacological Research
|January 22, 2020
Summary
Small molecules can alter protein shapes, revealing new therapeutic targets. This study highlights two cases where compounds hit unexpected protein sites, enabling inhibition of previously undruggable proteins.
Area of Science:
- Biochemistry
- Chemical Biology
- Drug Discovery
Background:
- Small molecules traditionally target protein biochemical activities.
- These molecules can also modulate protein conformational energy landscapes.
- Conformational modulation can uncover novel biological mechanisms with therapeutic implications.
Purpose of the Study:
- To explore the potential of small molecules in modulating protein conformations.
- To present examples of screening hits binding to unexpected protein pockets.
- To establish new strategies for inhibiting 'undruggable' proteins.
Main Methods:
- Screening of small molecule libraries.
- Identification of hits binding to novel allosteric sites.
- Characterization of protein-ligand interactions and functional consequences.
Main Results:
- Two examples demonstrating screening hits binding to unexpected pockets on known proteins.
- Discovery of new inhibition routes for previously intractable protein targets.
- Validation of the approach for identifying novel therapeutic strategies.
Conclusions:
- Small molecules offer a versatile approach to target protein conformation beyond traditional enzyme inhibition.
- Exploiting unexpected binding sites can overcome challenges posed by 'undruggable' targets.
- This strategy holds significant promise for advancing drug discovery and therapeutic development.
Keywords:
(E)-3-fluoro-N'-((5-(pyrimidin-2-ylthio)furan-2-yl)methylene) benzohydrazide (PubChem CID: 76554134)2-chloro-1-[2-[3-(trifluoromethyl)anilino]phenyl]ethanone (PubChem CID: 137796964)Allosteric inhibitorsChemical biologyDrug discoveryFlufenamic acid (PubChem CID: 3371)Iodoacetamide (PubChem CID: 3727)Structural biologyRelated Concept Videos
Labeling DNA Probes
9.1K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
9.1K
Drug Discovery: Overview
10.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K

